Eiger BioPharmaceuticals Inc (EIGRQ)

[Fezziwig2008]

New EIGR LAMBDA Trial in Canada -Why would Ontario be starting a new Lambda Trial without positive interim data in this SINGLE BLINDED trial - so Stanford researchers know that this 28 day follow up Trial is working and are sharing this fact with their colleagues in Canada. Dr Feld - Principal Investigator in Canada trained at the NIH and Hopkins.

Interferon Lambda for Immediate Antiviral Therapy at Diagnosis (ILIAD): A Phase II Randomized, Open-label, Multicenter Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19

Jordan Feld, Principal Investigator

University Health Network

Researchers will evaluate the drug peginterferon-lambda (PegIFN-) in ambulatory and hospitalized patients with mild to moderate COVID-19. Peginterferon-lambda has already been used to treat other viral diseases, such as hepatitis B and C. This research will shed light on whether it improves the ability of individuals to clear the virus that causes COVID-19.

https://news.ontario.ca/opo/en/2020/07/ontario-announces-next-round-of-research-projects-to-fight-covid-19.html